FDA Panel Recommends Approval of First Nasal Spray to Combat Severe Allergy Attacks
FRIDAY, May 12, 2023 (HealthDay News) — Outside advisors for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions. Although most of the Pulmonary-Allergy Drugs Advisory Committee members supported the spray for adults (16:6) and children (17:5),Continue Reading